NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 764 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,696,000 | -5.4% | 21,482 | -1.2% | 2.28% | +1.8% |
Q2 2016 | $1,793,000 | +14.6% | 21,732 | +0.6% | 2.24% | +13.9% |
Q1 2016 | $1,565,000 | -15.7% | 21,607 | +0.2% | 1.96% | -17.0% |
Q4 2015 | $1,856,000 | -8.9% | 21,567 | -2.7% | 2.36% | -14.3% |
Q3 2015 | $2,037,000 | -30.6% | 22,162 | -25.7% | 2.76% | -17.4% |
Q2 2015 | $2,934,000 | -0.9% | 29,833 | -0.7% | 3.34% | +1.4% |
Q1 2015 | $2,962,000 | +5.1% | 30,033 | -1.2% | 3.29% | +2.7% |
Q4 2014 | $2,817,000 | -1.4% | 30,407 | +0.1% | 3.20% | -3.4% |
Q3 2014 | $2,857,000 | +2.1% | 30,362 | -1.7% | 3.32% | +5.0% |
Q2 2014 | $2,797,000 | +4.4% | 30,897 | -2.0% | 3.16% | -0.3% |
Q1 2014 | $2,680,000 | +5.1% | 31,527 | -0.6% | 3.17% | +8.6% |
Q4 2013 | $2,549,000 | +0.5% | 31,722 | -4.0% | 2.92% | -7.3% |
Q3 2013 | $2,536,000 | +3.4% | 33,059 | -4.7% | 3.15% | +3.3% |
Q2 2013 | $2,453,000 | – | 34,699 | – | 3.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |